TIL (Tumor-infiltrating lymphocyte) therapy is an immunotherapy technique used in cancer treatment. TILs are a type of immune cell called T cells that are found inside tumors. In TIL therapy, these T cells are extracted from a patient's tumors, grown in the laboratory, and reinfused back into the patient to help their immune system recognize and destroy the cancer cells. TIL therapy is mainly used for treating melanoma and has shown promising results for cancers like cervical cancer, kidney cancer, and lung cancer. It offers long-lasting responses with complete tumor regression in some patients. Developing more standardized and reproducible techniques to extract, grow and reinfuse TILs is crucial to make this therapy accessible to a larger patient pool.
The Global TIL Therapy Market is estimated to be valued at US$ 0.087 Bn in 2024 and is expected to exhibit a CAGR of 78.% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global TIL Therapy Market are Iovance Biotherapeutics, Instil Bio, Obsidian Therapeutics, Cellectis. Iovance Biotherapeutics is a leading player in developing TIL therapies for several cancer indications. Instil Bio is conducting clinical trials to validate TIL therapies for solid tumors.
The key opportunities in the TIL therapy market include its successful clinical testing for additional tumor types beyond melanoma. Preliminary clinical trials show promise for cancers like cervical, kidney, and lung cancers providing major opportunities.
Global expansion of TIL therapy is anticipated with ongoing regulatory approvals and collaborations between key players. The partnerships help establish manufacturing facilities, expand clinical trials to new regions, and obtain regulatory clearances faster.
Market Drivers And Restrain
Market drivers- Significant clinical trial successes of TIL therapies like Iovance's lifileucel in late-stage melanoma patients have increased confidence in the approach. Newer strategies to extract TILs more easily and standardized large-scale manufacturing processes are accelerating product development.
Market restraints- High costs associated with developing personalized TIL therapies, long production timelines, and technical challenges in extracting suitable TILs from certain tumor types are some challenges faced by players. Limited understanding of factors defining response rates is also restricting wider adoption.
Segment Analysis
The global TIL therapy market can be segmented based on therapy type, application, and end user. Based on therapy type, the adoptive cell transfer therapy segment holds the largest share due to high success rates shown in clinical trials against solid tumors. It dominates the market as it involves extracting TILs from the patient's own tumor, growing them in large numbers, and infusing back to the patient to recognize and destroy tumor cells.
Based on application, the breast cancer segment leads due to high prevalence and increasing adoption of TIL therapy to treat breast cancer resistant to other therapies. It dominates the market as TIL therapy has demonstrated effectiveness even in late-stage breast cancer resistant to previously tried therapies.
Global Analysis
Regionally, North America captures the highest market share and is expected to maintain its dominance during the forecast period. This can be attributed to advanced healthcare facilities, high adoption of advanced cancer therapies including TIL, and presence of major market players in the region. The Asia Pacific region is projected to witness the highest growth rate due to increasing healthcare expenditure, growing cancer research, and rising patient awareness about advanced therapies for cancer treatment.
Get more insights on this topic: https://www.dailyprbulletin.com/global-til-therapy-market-is-set-for-robust-growth-by-rising-demand-for-cancer-immunotherapies/
Author Bio
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. (LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
What Are The Key Data Covered In This Global TIL Therapy Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global TIL Therapy Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global TIL Therapy Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global TIL Therapy Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global TIL Therapy Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global TIL Therapy Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global TIL Therapy Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global TIL Therapy Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it